Deals
Deals dated after 30 September 2026 are still being collected.
Columns
1 of 1 deals
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 2025 | Aptose Biosciences | – | HS North America | Acquisition | Financial adviser and fairness opinion to Aptose Biosciences (target) | Announced | – | Biotech+2 | Stikeman Elliott (buy-side) | HS North America acquisition of Aptose Biosciences |